Skip to content

The Effect of Perioperative Pregabalin on the Incidence of Chronic Post-thoracotomy Pain Syndrome

WithdrawnPhase 3NCT00998816
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

Brief summary (from the registry)

Pregabalin, administered prior to and following lateral thoracotomy surgery will reduce the likelihood of chronic post-thoracotomy pain syndrome (CPTPS).

Study details

Official title
A Multicenter Prospective Randomized Double-blind Placebo Controlled Trial Assessing the Effect of Perioperative Pregabalin on the Incidence of Chronic Post Thoracotomy Pain Syndrome
Conditions
Interventions
Sponsor
Queen's University
Collaborators
McMaster University
Start date
2012-05
Primary completion
2014-08
Sex
All
Age range
from 18 Years to 75 Years
Results posted
No results posted in this snapshot
Countries
Canada
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Elective open thoracotomy for primary thoracic surgery, understanding and provision of written informed consent, ASA class I II or III Exclusion Criteria: * Inability ot adhere to study protocol: * intolerance or hypersensitivity to any agents to be used in the study, contraindication to thoracic epidural placement * inability to respond to the study questionnaire * renal insufficiency(serum creatinine \> 1.5 upper limit of normal) * Body Mass index \> 40 * planned post-operative ventilation. * Confounding procedural factors which might affect validity of data: * previous ipsilateral thoracotomy * surgery for tumor extending into the chest wall * rest pain in proposed surgical area pre-operatively * chest tube in situ at time of surgery * requirement for second thoracotomy or re-occurrence of disease after surgery \*isolated pleuroscopy or pleurodesis procedures. * Potential interaction with study medications and patient's current medications: * current alcohol or other substance abuse * chronic steroid use * pre-existing chronic pain requiring chronic analgesic use * history of seizure disorder requiring treatment with an anticonvulsant * current therapy with thiazolidinedione class oral hypoglycemic agents (eg, Actos, Avandia or Avandamet) * history of congestive heart failure * major psychiatric disorder * any contraindication to use of NSAIDs. * Insufficient safety data in the patient population: * patients requiring preoperative assistance or assistive device for ambulation, pregnant or breastfeeding * weight \<50 Kg * dizziness while inpatient.

Canadian sites (1)

FacilityCityProvince
Dr. Jorge E ZamoraKingstonOntario

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00998816